Latest Breaking News On - Treating fibrotic liver tissue using - Page 1 : vimarsana.com

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update

Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMotti farbsteinKiryat matalonPnina fishmanFite biopharmaClinical development highlightsSoroka medical centerExchange commissionFite biopharma ltdTrademark office granted canEuropean medicines agencyDrug administrationCompany annual report on formWall streetClinical development highlights includePsoriasis trial met primary endpoint

Can-Fite Reports 2022 Financial Results & Provides Clinical Update

PETACH TIKVA, Israel (BUSINESS WIRE) Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory

United statesPnina fishmanMotti farbsteinFite biopharmaKiryat matalonSoroka medical centerTrademark office granted canExchange commissionClinical development highlightsCompany annual report on formFite biopharma ltdEuropean medicines agencyDrug administrationCan fite biopharmaClinical development highlights includeTrial met primary endpoint

2022-05-26 | NYSEAM:CANF | Press Release | Can-Fite Biopharma Ltd Sponsored ADR (Israel)

(2022-05-26 | NYSEAM:CANF) Can-Fite Reports First Quarter 2022 Financial Results & Provides Clinical Update

United statesPnina fishmanFite closecurlyquoteApremilast otezlaPiclidenoson closecurlyquoteExchange commissionTrademark officeIsrael patent officeFite biopharma ltdDrug administrationClinical development highlightsCan fite biopharmaClinical development highlights includeBalance sheetCan fite closecurlyquoteTopical psoriasis treatment